Public Meeting Announcement: Understanding How the Public Perceives and Values Pharmaceutical Quality – Drug Information Update

https://www.fda.gov/drugs/news-events-human-drugs/understanding-how-public-perceives-and-values-pharmaceutical-quality-02032020-02032020?utm_campaign=Public%20Meeting%20Understanding%20How%20the%20Public%20Perceives%20Values%20Pharmaceutical%20Quality&utm_medium=email&utm_source=Eloqua

Public Meeting Announcement: Understanding How the Public Perceives and Values Pharmaceutical Quality

The Robert J. Margolis, MD, Center for Health Policy at Duke University, in partnership with the U.S. Food and Drug Administration, is convening a public meeting entitled “Understanding How the Public Perceives and Values Pharmaceutical Quality.” This meeting will explore the role of quality in stakeholder decision-making.  Key FDA leadership and staff will provide comments on the agency’s current thinking, and there will be opportunities for attendees to ask questions and engage with panelists. Topics for discussion include: The importance of pharmaceutical quality; The current state of pharmaceutical quality; FDA’s role in regulating quality; and, Stakeholder perceptions of pharmaceutical quality. Stakeholders, including patients, providers, pharmacists, drug purchasers, and payers, may each consider quality when making decisions about pharmaceuticals. Register to attend in person, or for the livestream, by visiting this link. Date: Monday, February 3, 2020 Time: 9:30 a.m. to 11:30 a.m. Location: National Press Club, 529 14th St NW, Washington, DC 20045 or livestream

Read More